Here’s the presentation slides from our parents evening which explains the new Triple Therapy drug which will cover 3 classes of CF as opposed to just the double delta class of CF which Orkambi currently targets. Benefiting 90% of the CF Community.
Here’s the presentation slides from our parents evening which explains the new Triple Therapy drug which will cover 3 classes of CF as opposed to just the double delta class of CF which Orkambi currently targets. Benefiting 90% of the CF Community.
Just Breathe Cornwall 